Chemotherapy-free regimens in frontline follicular lymphoma

被引：0
|
作者：
Batlevi, Connie Lee [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2022年 / 139卷 / 15期
关键词：
LENALIDOMIDE;
D O I：
10.1182/blood.2021015120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lenalidomide and anti-CD20-based combinations have validated efficacy in treatment of follicular lymphoma in both the frontline and the relapsed settings. In this issue of Blood, Bachy et al(1) report the tolerability and efficacy of obinutuzumab and lenalidomide in the frontline therapy of follicular lymphoma.
引用
收藏
页码：2263 / 2264
页数：3
相关论文
共 50 条
  • [21] Novel Agents for Follicular Lymphoma
    Leonard, John P.
    Martin, Peter
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 259 - 264
  • [22] Immunomodulatory Agents in Follicular Lymphoma
    Ysebaert, Loic
    Morschhauser, Franck
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (04) : 715 - +
  • [23] Current and future therapies for follicular lymphoma
    Zinzani, Pier Luigi
    Munoz, Javier
    Trotman, Judith
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [24] Therapeutic targeting of microenvironment in follicular lymphoma
    Nowakowski, Grzegorz S.
    Ansell, Stephen M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 169 - 173
  • [25] Recent landmark studies in follicular lymphoma
    Sorigue, Marc
    Sancho, Juan-Manuel
    BLOOD REVIEWS, 2019, 35 : 68 - 80
  • [26] Immune Responses and Outcome in Follicular Lymphoma
    Gribben, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) : 1757 - 1759
  • [27] Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma
    Rutherford, Sarah C.
    Yin, Jun
    Pederson, Levi D.
    Blum, Kristie A.
    Martin, Peter
    Jung, Sin -Ho
    Grant, Barbara
    Rosenbaum, Cara
    Cheson, Bruce D.
    Bartlett, Nancy L.
    Mandrekar, Sumithra J.
    Leonard, John P.
    BLOOD ADVANCES, 2024, 8 (06) : 1464 - 1468
  • [28] The Optimal Management of Follicular Lymphoma: An Evolving Field
    Chaitra Ujjani
    Bruce D. Cheson
    Drugs, 2013, 73 : 1395 - 1403
  • [29] Novel agents for relapsed and refractory follicular lymphoma
    Cheah, Chan Yoon
    Fowler, Nathan H.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (01) : 41 - 48
  • [30] Treatment of high-risk follicular lymphoma
    Jurczak, Wojciech
    HEMASPHERE, 2019, 3 : 85 - 87
12345